DISEASE ADVANCES

Here are some of the latest cancer breakthroughs in research, testing, and treatment.

Predicting an individual’s risk of ischemic stroke is difficult because thrombosis embolization—the process of a blood clot detaching from the area where it formed, traveling and then sticking in another blood vessel—is based on factors unique to each person.

University of Virginia Comprehensive Cancer Center scientists have developed a promising new experimental approach to targeting glioblastoma, the most common and deadliest brain cancer.

Clinical case study challenges established paradigms on permanent cognitive and motor decline in age-related degenerative diseases.

Capsules containing donor stool microbes improved sleep efficiency and reduced nighttime wakefulness in adults with chronic insomnia.

Prions can turn the body’s own proteins into a threat, and studying this group of diseases could help us better understand dementia.

Seizures can race through the brain in seconds, making them difficult to capture in detail. To overcome this challenge, researchers have developed a new high-resolution light-sheet imaging system that is fast enough to image seizure propagation in the brain of a larval zebrafish in 3D.

Photodynamic therapy (PDT) uses a light-sensitive drug and a specific wavelength of light to destroy cancer cells. The treatment has become an important option for certain skin cancers because it can target diseased tissue while limiting damage to surrounding skin. But PDT has a fundamental challenge: both the drug and the light must reach the same area of tissue.